The Hon'ble NCLT vide its Order dated October 21, 2022 ('NCLT Order'), the certified copy of which was issued on November 14, 2022, confirmed the reduction of 82,03,005 (Eighty Two Lakh Three Thousand and Five) equity shares having face value of INR 1/- (Indian Rupee One only) each fully paid-up, aggregating to INR 82,03,005 (Indian Rupees Eighty Two Lakh Three Thousand and Five Only) constituting approx. 14.83% (Fourteen Point Eight Three percent) of the total Issued, Subscribed and Paid-up Equity Share Capital of the Pharmax, held by the non-promoters/ public category Shareholders, i.e., other than Max Estates Limited in accordance with the provisions of Section 66 and other applicable provisions of the Companies Act, 2013 Further, the copy of NCLT Order has been filed with the ROC on December 7, 2022 Consequent to which the abovementioned capital reduction has become effective and the Pharmax has become wholly owned subsidiary of Max Estates Limited.